| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
19,144 |
11,889 |
$5.58M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,787 |
4,470 |
$2.26M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,122 |
3,668 |
$2.19M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
9,915 |
7,547 |
$1.88M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,999 |
2,277 |
$1.26M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,059 |
1,279 |
$562K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,347 |
1,759 |
$500K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
10,734 |
7,987 |
$478K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
431 |
369 |
$281K |
| 71046 |
Radiologic examination, chest; 2 views |
913 |
741 |
$226K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,584 |
1,172 |
$220K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,577 |
1,401 |
$183K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,344 |
1,570 |
$176K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
218 |
204 |
$151K |
| 92015 |
Determination of refractive state |
1,649 |
1,482 |
$134K |
| 71045 |
Radiologic examination, chest; single view |
502 |
387 |
$129K |
| 70450 |
Computed tomography, head or brain; without contrast material |
73 |
57 |
$121K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
309 |
265 |
$116K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,130 |
1,630 |
$109K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
28 |
24 |
$95K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
255 |
203 |
$92K |
| 80053 |
Comprehensive metabolic panel |
7,606 |
5,701 |
$68K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,218 |
1,795 |
$65K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,214 |
1,794 |
$65K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
498 |
253 |
$60K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,949 |
6,624 |
$59K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,732 |
1,560 |
$52K |
| 93976 |
|
64 |
52 |
$42K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,662 |
1,493 |
$41K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,334 |
2,002 |
$34K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,635 |
1,233 |
$31K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
82 |
70 |
$31K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
30 |
26 |
$28K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
127 |
112 |
$25K |
| 0240U |
|
199 |
181 |
$24K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,488 |
1,036 |
$24K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,352 |
2,077 |
$23K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
48 |
40 |
$20K |
| 84703 |
|
2,785 |
2,101 |
$17K |
| 94760 |
|
136 |
101 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,963 |
1,721 |
$16K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
64 |
54 |
$14K |
| 84439 |
|
1,862 |
1,592 |
$14K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,061 |
1,643 |
$14K |
| 80061 |
Lipid panel |
1,207 |
1,074 |
$14K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
430 |
386 |
$13K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
37 |
34 |
$12K |
| 81001 |
|
4,033 |
3,136 |
$11K |
| 86710 |
|
847 |
706 |
$10K |
| 84484 |
|
960 |
637 |
$10K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
762 |
542 |
$9K |
| 83690 |
|
1,542 |
1,191 |
$9K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
572 |
525 |
$9K |
| 83735 |
|
1,346 |
970 |
$7K |
| 83880 |
|
214 |
145 |
$6K |
| 73630 |
|
14 |
12 |
$6K |
| 36000 |
|
44 |
36 |
$6K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
217 |
197 |
$5K |
| 94644 |
|
39 |
32 |
$4K |
| J3490 |
Unclassified drugs |
55 |
25 |
$4K |
| M0240 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses |
18 |
16 |
$4K |
| 87430 |
|
386 |
318 |
$3K |
| 81002 |
|
943 |
703 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
612 |
507 |
$2K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
55 |
51 |
$2K |
| 85610 |
|
511 |
385 |
$2K |
| 87210 |
|
471 |
364 |
$2K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
84 |
78 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
226 |
153 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
577 |
420 |
$1K |
| 87420 |
|
119 |
78 |
$1K |
| 0002A |
|
60 |
25 |
$937.34 |
| 82607 |
|
65 |
60 |
$857.31 |
| 36415 |
Collection of venous blood by venipuncture |
1,650 |
1,335 |
$812.96 |
| 83605 |
|
75 |
50 |
$753.84 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
23 |
23 |
$652.49 |
| 86592 |
|
170 |
160 |
$618.94 |
| 87040 |
|
52 |
27 |
$525.84 |
| 84702 |
|
28 |
24 |
$398.30 |
| 86803 |
|
26 |
25 |
$355.33 |
| 87081 |
|
71 |
60 |
$344.43 |
| 87070 |
|
45 |
38 |
$330.21 |
| 86140 |
|
62 |
57 |
$310.95 |
| 82728 |
|
29 |
24 |
$299.86 |
| 82947 |
|
106 |
72 |
$299.36 |
| 86850 |
|
30 |
24 |
$224.71 |
| 85651 |
|
61 |
55 |
$217.77 |
| J2060 |
Injection, lorazepam, 2 mg |
28 |
14 |
$216.90 |
| 80179 |
|
13 |
12 |
$205.04 |
| 82746 |
|
16 |
14 |
$191.10 |
| 87340 |
|
12 |
12 |
$123.44 |
| 83550 |
|
17 |
12 |
$87.40 |
| 83540 |
|
18 |
13 |
$71.17 |
| 86901 |
|
30 |
24 |
$68.77 |
| 86900 |
|
30 |
24 |
$68.77 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
12 |
$62.10 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
14 |
13 |
$34.99 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
12 |
12 |
$9.40 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
15 |
13 |
$2.25 |
| 80320 |
|
1,672 |
1,183 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
103 |
84 |
$0.00 |
| 0001A |
|
65 |
44 |
$0.00 |
| 80329 |
|
86 |
37 |
$0.00 |
| 90474 |
|
14 |
14 |
$0.00 |
| D0120 |
Periodic oral evaluation - established patient |
17 |
13 |
$0.00 |
| D1206 |
Topical application of fluoride varnish |
67 |
29 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
51 |
14 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
67 |
65 |
$0.00 |
| 0003A |
|
32 |
30 |
$0.00 |
| 96381 |
|
12 |
12 |
$0.00 |
| 85048 |
|
21 |
15 |
$0.00 |
| 85004 |
|
21 |
15 |
$0.00 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
21 |
14 |
$0.00 |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
16 |
15 |
$0.00 |
| D1120 |
Prophylaxis - child |
13 |
12 |
$0.00 |